Pages that link to "Q28306356"
Jump to navigation
Jump to search
The following pages link to Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB (Q28306356):
Displaying 50 items.
- PI3K/AKT/mTOR Pathway in Angiogenesis (Q21129332) (← links)
- Akt and mTOR in B Cell Activation and Differentiation (Q21131224) (← links)
- Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease (Q21136406) (← links)
- Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2 (Q21145847) (← links)
- Timosaponin AIII is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress (Q21562347) (← links)
- PHLPP-Mediated Dephosphorylation of S6K1 Inhibits Protein Translation and Cell Growth (Q24292938) (← links)
- Activation of mTORC2 by Association with the Ribosome (Q24294876) (← links)
- The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 (Q24297392) (← links)
- Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes (Q24297874) (← links)
- Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR (Q24300205) (← links)
- PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms (Q24300933) (← links)
- Identification of Protor as a novel Rictor-binding component of mTOR complex-2 (Q24303936) (← links)
- B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer (Q24307014) (← links)
- SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth (Q24309283) (← links)
- DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival (Q24311448) (← links)
- The target of rapamycin complex 2 controls dendritic tiling of Drosophila sensory neurons through the Tricornered kinase signalling pathway (Q24312720) (← links)
- Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities (Q24316273) (← links)
- Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells (Q24318126) (← links)
- A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2 (Q24319028) (← links)
- Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling (Q24323370) (← links)
- mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) (Q24324148) (← links)
- Regulation of TOR by small GTPases (Q24598385) (← links)
- Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity (Q24598427) (← links)
- Potential use of rapamycin in HIV infection (Q24606795) (← links)
- Updates of mTOR inhibitors (Q24607170) (← links)
- Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism (Q24608263) (← links)
- Spatial regulation of the mTORC1 system in amino acids sensing pathway (Q24612853) (← links)
- Discovery of 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a highly potent, selective mammalian target of rapamycin (mTOR) inhibitor for the treatment of cancer (Q24617184) (← links)
- Cholesterol trafficking is required for mTOR activation in endothelial cells (Q24620236) (← links)
- Pushing the envelope in the mTOR pathway: the second generation of inhibitors (Q24622222) (← links)
- The mTOR signalling pathway in human cancer (Q24627306) (← links)
- Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy (Q24628724) (← links)
- An emerging role for TOR signaling in mammalian tissue and stem cell physiology (Q24629305) (← links)
- Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony (Q24629514) (← links)
- Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance (Q24630201) (← links)
- The PI3K pathway as drug target in human cancer (Q24632283) (← links)
- Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy (Q24632296) (← links)
- Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly (Q24632884) (← links)
- mTOR: from growth signal integration to cancer, diabetes and ageing (Q24633662) (← links)
- mTOR signaling in growth control and disease (Q24634174) (← links)
- Regulation of mRNA export by the PI3 kinase/AKT signal transduction pathway (Q24634371) (← links)
- Rapamycin and mTOR kinase inhibitors (Q24644623) (← links)
- Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1 (Q24645183) (← links)
- The TSC1-TSC2 complex: a molecular switchboard controlling cell growth (Q24645204) (← links)
- Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy (Q24645466) (← links)
- mTOR signaling: at the crossroads of plasticity, memory and disease (Q24647655) (← links)
- Rheb and mTOR regulate neuronal polarity through Rap1B (Q24651133) (← links)
- A complex interplay between Akt, TSC2 and the two mTOR complexes (Q24655791) (← links)
- mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice (Q24658113) (← links)
- Targeting the mTOR signaling network for cancer therapy (Q24658334) (← links)